Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
REVENUES
Product revenue, net	$ 72,140	$ (163,971)	$ 231,622	$ (452,531)
License and contract	250,000	0	250,000	0
Revenue	250,000	(163,971)	481,622	(452,531)
OPERATING EXPENSES
Cost of products sold	29,171	29,400	83,104	54,600
Research and development	5,426,397	4,011,418	8,911,161	6,935,269
Selling, general and administrative	3,317,760	5,044,913	7,154,302	7,376,519
Gain on license termination agreement	0	0	0	(1,623,795)
Total operating expenses	8,773,328	9,085,731	16,148,567	12,742,593
Loss from operations	(8,451,188)	(9,249,702)	(15,666,945)	(13,195,124)
OTHER INCOME (EXPENSE)
Investment income	1,563	4,800	2,973	16,935
Foreign currency loss	(234,078)	(745,002)	(126,719)	(745,002)
Interest expense	(2,773)	(1,871)	(8,404)	(9,360)
Total other expense, net	(235,288)	(742,073)	(132,150)	(737,427)
NET LOSS	$ (8,686,476)	$ (9,991,775)	$ (15,799,095)	$ (13,932,551)
Basic and diluted net loss per common share	$ (0.04)	$ (0.04)	$ (0.07)	$ (0.06)
Weighted average number of common shares outstanding used in computing basic and diluted net loss per common share	238,276,793	236,405,065	238,256,318	236,375,463